Bill > S0784

This bill requires the Agency for Health Care Administration to seek federal approval within 30 days of becoming law to provide Medicaid coverage for continuous glucose monitors (CGMs) and related supplies as a durable medical equipment (DME) benefit. Continuous glucose monitors are medical devices that help people with diabetes track their blood sugar levels in real-time. The bill mandates that licensed DME providers must be reimbursed for CGMs when they submit claims through the Medicare Healthcare Common Procedure Coding System, and the agency cannot require providers to use a National Drug Code number when submitting these claims. The bill also clarifies that the agency is not prevented from providing additional CGM coverage through the Medicaid pharmacy benefit. The agency is instructed to begin implementing these changes once it receives the necessary federal approval, and the act will take effect immediately upon becoming law. This legislation aims to improve access to important medical technology for Medicaid recipients with diabetes by ensuring coverage of continuous glucose monitors.

https://www.flsenate.gov/Session/Bill/2026/784